Sir, The treatment of choriocarcinoma forms one of the success stories of oncology with survival rates of nearly 100% in low-risk group and more than 90% in the high-risk group. [1] It is a unique neoplasm with a great propensity for spread by hematogenous route, including to the brain. The central nervous system (CNS) metastasis is often hemorrhagic and thormbotic complications are extremely rare.
A 30-year-old lady presented with bleeding per vaginum of two months duration. The obstetric history revealed a normal delivery five years back, a spontaneous abortion four years back, and a molar pregnancy two years back for which evacuation was done. Serum human chorionic gonadotropin (HCG) was 90000 IU. Computerized tomography (CT) of the chest revealed multiple bilateral lung metastasis. CT of the brain was normal.
Based on the history and high HCG values, she was diagnosed to have choriocarcinoma, stage III high risk (WHO score 8), and was initiated on etoposide, methotrexate, actinomycin-D, cyclophosphamide, and vincristine (EMACO) chemotherapy. She responded to treatment with dropping HCG values. After two cycles of the therapy, she had an episode of generalized tonic-clonic seizures. Magnetic resonance imaging (MRI) was suggestive of cerebral venous thrombosis [ Figure 1 ]. Enoxaparin treatment was initiated and was later continued on warfarin. Once her general condition improved EMACO was reinitiated. After two more cycles of the therapy, she had sudden onset right-sided hemiparesis and MRI brain this time was suggestive of left temporal lobe infarct with edema [ Figure 2 ]. Coagulation screening including serum Letters to Editor antiphospholipid antibody was normal. Echocardiogram did not reveal any vegetations or septal defects. She was continued on anticoagulants which was stopped only after HCG normalized.
The patient received six cycles of chemotherapy, her HCG values normalized and now she has completed 15 months of follow up. She is in remission and does not have any residual neurological deficits.
Gestation trophoblastic neoplasia represents one of the success stories of modern-era chemotherapy in the treatment of human malignancy. The incidence of choriocarcinoma varies from 1 in 120 pregnancies in some parts of Asia to 1 in 1200 in United States. [1] Choriocarcinoma has the propensity for vascular invasion and widespread metastasis, including to the brain. CNS metastasis is usually hemorrhagic and our patient had normal study of brain upfront and developed the neurological events while on treatment. CNS in volvement in Choriocarcinoma can be due to hemorrhagic metastas, tumor embolization and chemotherapy (especially platinum compounds). CNS thrombotic events are extremely rare. The association between cancer and thrombosis was identified in 1865 and the combination is called as Trousseau syndrome. [2] The mechanisms elucidated include cytokines like TNFa, IL-1, and IL-6 that cause endothelial damage resulting in thrombosis. [3] The interaction between tumor cells and macrophages activates platelets and factors XII and X, which leads to thrombin generation and thrombosis. The various chemotherapeutic agents including platinum compounds can cause endothelial damage. Central venous catheters and total parenteral nutrition also increase the risk.
Lepidini et al. reported a patient with pure testicular choriocarcinoma who suffered from both arterial and venous thrombosis during chemotherapy. [4] An increased paraneoplastic stimulus of HCG, secondary to the marker surge phenomenon, was suggested as responsible for transient hypercoagulability and subsequent thromboembolism. Komeichi et al. had an interesting case of metastatic choriocarcinoma associated with cerebral thrombosis and aneurysmal formation. [5] The aneurysmal wall was invaded by choriocarcinoma. To the best of our knowledge, this is the first reported case of choriocarcinoma with cerebral venous thrombosis during the course of the treatment. Cerebral thrombotic events also should be borne in mind, when a patient with choriocarcinoma presents with focal deficits. 
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Hypertrophic olivary degeneration: The forgotten triangle of Guillain and Mollaret
Sir, Hypertrophic olivary degeneration (HOD), a form of transsynaptic degeneration, results from a lesion of the dento-rubro-olivary pathway (also called the anatomical triangle of Guillain and Mollaret).
The degeneration is unique in that it is associated, at least for a period of time, with the hypertrophy rather than atrophy of inferior olivary nucleus. [1] We present two cases of HOD. The clinical presentation was dentatorubral tremor in both cases, but palatal myoclonus, the hallmark of this disorder, had not yet developed in either.
A 50-year-old man, with a history of old pontine infarct resulting in right-sided facial and trigeminal palsy, presented with progressively worsening upper extremity tremor and cerebellar signs. Neurological examination revealed weakness of right masticatory muscles, facial hemianesthesia and cerebellar signs. Palatal myoclonus was not observed. Magnetic resonance imaging (MRI) of the brain revealed cystic encephalomalacia in the deep dorsal pons in right paraventricular location (the site of motor and sensory nucleus of the trigeminal nerve). In addition, the ipsilateral inferior olivary nucleus showed hyperintense signal on T2/PD images suggestive of HOD. Striking cerebellar cortical atrophy was evident on the contralateral side. The right pterygoid, masetter and temporalis muscles showed denervation atrophy (manifested by hyperintense T2/FLAIR signal) secondary to the initial infarct [ Figures 1-4] .
A 45-year-old female, with a past history of nonhypertensive right cerebellar hemorrhage documented by a computerized tomography (CT) underwent magnetic resonance imaging (MRI) of brain for recent onset of upper limb tremor. MRI revealed a chronic deep right cerebellar hemorrhage (manifested as hypointensity on T2 weighted images-due to hemosiderin staining); hyperintense signal on T2/PD/FLAIR images, consistent with HOD was seen on opposite side [ Figure 5 ].
The anatomical triangle of Guillian and Mollaret consists of a central tegmental tract connecting red nucleus to inferior olivary nucleus, dentatorubral tract (connecting dentate nucleus to contralateral red nucleus via superior cerebellar peduncle), and inferior cerebellar peduncle connecting inferior olivary nucleus to contralateral cerebellar cortex and dentate nucleus. [1] The dentatorubral
